#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Lymphangiosarcoma Hereditary hypophosphataemic rickets Salivary gland cancer Liposarcoma Pulmonary alveolar haemorrhage Glomerulonephritis Alport's syndrome Renal cell carcinoma Giant cell tumour of tendon sheath Endometrial cancer Hepatoblastoma Obesity Interstitial lung disease Mitochondrial myopathy Biotinidase deficiency More trials…

    Learn about Rare Diseases

    Usher’s syndrome – Diagnostics Breast angiosarcoma – Diagnostics Aicardi-Goutieres syndrome Choroid melanoma – Trials in Disease Activated PI3 kinase delta syndrome – Basic Information MELAS syndrome – Treatment Osteosarcoma metastatic – Basic Information Turner’s syndrome – Treatment Rhabdoid tumour – Life with Disease Focal segmental glomerulosclerosis – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tretinoin Levobupivacaine Hydrochloride Daptomycin Colistimethate Sodium BI 456906 Grwd5769 Remdesivir Pimecrolimus Pf-06480605 Ceftriaxone GRNA1599 Lithium Carbonate Artemisia Vulgaris (312) Gad20-209-Fsp-A3 Sodium 2-Hydroxylinoleate Oms906 Syn2 Avelumab Df1001 Phleum Pratense (225) More therapies…

    Learn about Your Condition

    Propionic acidaemia Hepatobiliary disease Bipolar I disorder Deafness neurosensory Brain abscess Metastases to peritoneum Genital herpes Thrombotic microangiopathy Malignant peritoneal neoplasm Procedural anxiety Fabry's disease Colitis ulcerative Solitary fibrous tumour Hypotonia Malignant oligodendroglioma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Bronchiectasis

  • Study on the Effects of 7% Hypertonic Saline Inhalation and ELTGOL Physiotherapy for Patients with Bronchiectasis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Bronchiectasis
    Investigated Drugs:
    • Mannitol
    • Sodium Chloride Ph. Eur.
    Spain

  • Study Comparing Ciprofloxacin, Colistimethate Sodium, and Ceftazidime for Treating Early Airway Infection in Adults with Bronchiectasis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Bronchiectasis
    Investigated Drugs:
    • Colistimethate Sodium
    • Ceftazidime Pentahydrate
    • Ciprofloxacin
    France

  • A Study of SAR445399 in Adults Aged 18‑80 with Non‑cystic Fibrosis Bronchiectasis

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Bronchiectasis
    Investigated Drugs:
    • SAR445399
    France Germany The Netherlands Poland Spain

  • Efficacy of colistimethate sodium and ciprofloxacin for eradicating primary Pseudomonas aeruginosa infection in adults with bronchiectasis

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Bronchiectasis
    Investigated Drugs:
    • Colistimethate Sodium
    • Ciprofloxacin
    • Sodium Chloride
    Spain

  • Study of Nebulized Human Normal Immunoglobulin (CSL787) for Adults with Non-cystic Fibrosis Bronchiectasis to Find Best Dose and Test Safety

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Bronchiectasis
    Investigated Drugs:
    • Human Normal Immunoglobulin
    Belgium Denmark France Germany Greece Hungary +4

  • Study on Inhaled Tobramycin and Colistimethate Sodium for Adults with Chronic Bronchial Infection in Bronchiectasis

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Bronchiectasis
    Investigated Drugs:
    • Colistimethate Sodium
    • Tobramycin
    Spain
Previous Page
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!